Megace 40 suspension

Megace (E.R. Squibb & Sons, L.L.C.), manufactured drug form of Megestrol acetate, 40mg/mL megestrol acetate suspension, NDC 0015-0508

Available in:

NDC Product ID:

  • 0015-0508

Manufacturer:

Manufactured drug form

Manufactured form of:

Generic drug:

  • No

Label date:

  • Mar 1, 2011

Label link:

Label sections:

Section name Section URI Prominent warning Section LOINC code
  • Description
  • No
  • 34089-3
  • Clinical Pharmacology
  • No
  • 34090-1
  • Description Of Clinical Studies
  • No
  • 34092-7
  • Indications And Usage
  • No
  • 34067-9
  • Contraindications
  • No
  • 34070-3
  • Warnings
  • No
  • 34071-1
  • Precautions
  • No
  • 42232-9
  • Adverse Reactions
  • No
  • 34084-4
  • Overdosage
  • No
  • 34088-5
  • Dosage And Administration
  • No
  • 34068-7
View entire collection »

Discontinued:

  • No

Marketing start date:

  • Jun 1, 2009

Patents:

Patent expiry date:

  • Aug 16, 2011

FDA application number:

  • NDA020264

Flavor:

View entire collection »

Therapeutic equivalents:

View entire collection »
top ↑

Consumer product

Brand:

top ↑

You can help improve this topic by adding more facts here

Edit this topic
Edit and Show details

Add or delete facts, download data in JSON or RDF formats, and explore topic metadata.

Freebase Logo
What is Freebase?

Freebase is a huge collection of facts, built by people like you. Freebase connects facts in ways other sites can't, giving you new ways to explore millions of subjects.
You can help improve it!